Estrogen up-regulation of p53 gene expression in MCF-7 breast cancer cells is mediated by calmodulin kinase IV-dependent activation of a nuclear factor κB/CCAAT-binding transcription factor-1 complex

Molecular Endocrinology

Volumn 16, Issue 8, 2002, Pages 1793-1809

  Qin, Chunhua ^a   Nguyen, Thu ^a   Stewart, Jessica ^a   Samudio, Ismael ^a   Burghardt, Robert ^a   Safe, Stephen ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CATHEPSIN D; CCAAT BINDING FACTOR; EGTAZIC ACID; ESTRADIOL; ESTROGEN; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN P53; SYNAPTOTAGMIN; CCAAT ENHANCER BINDING PROTEIN; CTF 1 TRANSCRIPTION FACTOR; CTF-1 TRANSCRIPTION FACTOR; DNA; NUCLEAR FACTOR I; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA;

ARTICLE; BREAST CANCER; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOSOL; ESTROGEN RESPONSIVE ELEMENT; GENE DELETION; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; BREAST TUMOR; CELL CULTURE; DRUG EFFECT; FEMALE; GENETICS; MACROMOLECULE; METABOLISM; NUCLEOTIDE SEQUENCE; PROTEIN TERTIARY STRUCTURE; TRANSACTIVATION; TUMOR SUPPRESSOR GENE; UPREGULATION;

BASE SEQUENCE; BREAST NEOPLASMS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CCAAT-ENHANCER-BINDING PROTEINS; DNA, NEOPLASM; ESTRADIOL; FEMALE; GENES, P53; HUMAN; MACROMOLECULAR SYSTEMS; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, TERTIARY; SEQUENCE DELETION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION; HUMANS; MACROMOLECULAR SUBSTANCES; NFI TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR RELA;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0036020402     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2002-0006     Document Type: Article

References (82)

1. p53, the cellular gatekeeper for growth and division
2. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies
3. The complexity of p53 modulation: Emerging patterns from divergent signals
4. The p53 pathway and apoptosis
5. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
6. WAF1, a potential mediator of p53 tumor suppression
7. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
8. p53 inhibits DNA replication in vitro in a DNA-binding-dependent manner
9. Wild-type p53 binds to the TATA-binding protein and represses transcription
10. p53 modulation of TFIIH-associated nucleotide excision repair activity
11. Cooperative DNA binding of p53 with TFIID (TBP): A possible mechanism for transcriptional activation
12. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3
13. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
14. p53: At the crossroads of molecular carcinogenesis and risk assessment
15. Apoptosis, cancer and the p53 tumour suppressor gene
16. P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers
17. Tumor suppressor p53 mutations and breast cancer: A critical analysis
18. Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line
19. Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells
20. Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells
21. 2+/calmodulin-dependent protein kinase IV stimulates nuclear factor-κB transactivation via phosphorylation of the p65 subunit
22. Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene
23. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription
24. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression
25. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells
26. Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression
27. YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity
28. Coexamination of site-specific transcription factor binding and promoter activity in living cells
29. Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements
30. Transcriptional activation of rat creatine kinase B by 17β-estradiol in MCF-7 cells involves an estrogen responsive element and GC-rich sites
31. Functional synergy between the transcription factor Sp1 and the estrogen receptor
32. Cooperative coactivation of estrogen receptor α in ZR-75 human breast cancer cells by SNURF and TATA-binding protein
33. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription
34. Transcriptional activation of E2F1 gene expression by 17β-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions
35. Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells
36. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens
37. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions
38. ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
39. ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor
40. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium
41. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERα and ERβ expressed in Chinese hamster ovary cells
42. Rapid membrane effects of steroids in neuroblastoma cells: Effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription
43. Estrogens cause rapid activation of IP3-PKC-α signal transduction pathway in HEPG2 cells
44. Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription
45. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
46. The ankyrin repeat domains of the NF-κB precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-κB DNA binding
47. Synergistic transcriptional activation by CTF/NF-I and the estrogen receptor involves stabilized interactions with a limiting target factor
48. Nuclear factor κB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum
49. Signal transduction through NF-κB
50. NF-κB activation
51. IκBα degradation and nuclear factor-κB DNA binding are insufficient for interleukin-1β and tumor necrosis factor-α-induced κB-dependent transcription. Requirement for an additional activation pathway
52. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor
53. Differential IκB kinase activation and IκBα degradation by interleukin-1β and tumor necrosis factor-α in human U937 monocytic cells. Evidence for additional regulatory steps in κB-dependent transcription
54. Oncogenic Ha-Ras-induced signaling activates NF-κB transcriptional activity, which is required for cellular transformation
55. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor
56. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α
57. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1
58. Coordinate regulation of IκB kinases by mitogen-activated protein kinase 1 and NF-κB-inducing kinase
59. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown
60. Analysis of the role of protein kinase C-α, -ε, and -ζ in T cell activation
61. ζPKC induces phosphorylation and inactivation of IκB α in vitro
62. Protein kinase C ζ isoform is critical for κB-dependent promoter activation by sphingomyelinase
63. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism
64. Characterization of IκB kinases. IκBα is not phosphorylated by Raf-1 or protein kinase C isozymes, but is a casein kinase II substrate
65. Akt suppresses apoptosis by stimulating the transactivation potential of the ReIA/p65 subunit of NF-κB
66. NF-κ B is a target of AKT in anti-apoptotic PDGF signalling
67. 2+/CaM-dependent kinases: From activation to function
68. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ
69. 2+ entry in human endometrial cells
70. 2+ influx and down regulates interleukin-2 receptor in mouse thymocytes
71. 2+]i by 17β-oestradiol in female rat distal colon
72. Proteasome-mediated proteolysis of estrogen receptor: A novel component in autologous down-regulation
73. Proteasome-dependent degradation of the human estrogen receptor
74. The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation
75. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells
76. Estrogen activates raf-1 kinase and induces expression of Egr-1 in MCF-7 breast cancer cells
77. BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen
78. Hormone-dependent regulation of BRCA1 in human breast cancer cells
79. Estrogen receptor protects p53 from deactivation by human double minute-2
80. BRCA1 inhibition of estrogen receptor signaling in transfected cells
81. The proteasome, a novel protease regulated by multiple mechanisms
82. Ubiquitin-mediated proteolysis: Biological regulation via destruction